Literature DB >> 17355091

Hepatitic inherited metabolic disorders.

May Arroyo1, James M Crawford.   

Abstract

Primary metabolic disorders are a disparate group of diseases that may or may not be accompanied by hepatic manifestations. Those with liver involvement may show a range of histopathologic changes. Proper histologic diagnosis requires correlation with clinical and laboratory data, including evaluation for mutations either via serum protein electrophoresis or through formal genetic analysis. This article is a review of the three most common inherited metabolic disorders which may present with a hepatitic pattern. In alpha1-antitrypsin disorder, there is a broad range of clinical presentations, age at presentation, and histological features ranging from "neonatal hepatitis" to a chronic progressive hepatitis in later childhood and adulthood. Hence, this disorder must be in the differential diagnosis of liver disease of the very young, and in older children and adults, with or without coexistent overt pulmonary symptoms. In Wilson disease, presentation tends to be in older childhood or the adult, with a progressive chronic hepatitis. Cystic fibrosis may feature a characteristic obstructive biliary syndrome, coexisting with the many extrahepatic manifestations of this debilitating disease. Lastly, the progressive familial intrahepatic cholestasis (PFIC) syndromes are given as examples of inherited metabolic conditions in which relentlessly progressive cholestatic liver disease eventuates over years in end-stage cholestatic liver disease with cirrhosis. Distinguishing features include absence of elevated serum gamma-glutamyl transpeptidase (GGT) in PFIC-1 and PFIC-2, and elevated GGT in PFIC-3. However, molecular studies are required for a confident diagnosis of the rare PFIC syndromes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17355091     DOI: 10.1053/j.semdp.2006.11.005

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  5 in total

Review 1.  Stem cell therapy for inherited metabolic disorders of the liver.

Authors:  Susan Ellor; Thomas Shupe; Bryon Petersen
Journal:  Exp Hematol       Date:  2008-04-02       Impact factor: 3.084

Review 2.  Transient elastography for assessment of fibrosis in paediatric liver disease.

Authors:  Valerio Nobili; Lidia Monti; Anna Alisi; Cristina Lo Zupone; Andrea Pietrobattista; Paolo Tomà
Journal:  Pediatr Radiol       Date:  2011-06-16

Review 3.  Potential applications for cell regulatory factors in liver progenitor cell therapy.

Authors:  Thomas Shupe; Bryon E Petersen
Journal:  Int J Biochem Cell Biol       Date:  2010-09-21       Impact factor: 5.085

Review 4.  The Role of Bile Acids in the Human Body and in the Development of Diseases.

Authors:  Yulia Shulpekova; Maria Zharkova; Pyotr Tkachenko; Igor Tikhonov; Alexander Stepanov; Alexandra Synitsyna; Alexander Izotov; Tatyana Butkova; Nadezhda Shulpekova; Natalia Lapina; Vladimir Nechaev; Svetlana Kardasheva; Alexey Okhlobystin; Vladimir Ivashkin
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

5.  Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019.

Authors:  David Ricardo da Conceição Marçal Alves Nunes; Michèle Claire Breton; Cristina Sofia de Jesus Monteiro; Jorge Luiz Dos Santos
Journal:  Healthcare (Basel)       Date:  2021-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.